Presentation: Vaccine development using two immunopotent viral vectors

download, vaccine development, viral vector-based, World Vaccine Congress 2013

In November 2012 over 200 delegates participated in the 13th Annual World Vaccine Congress Lyon in France. This event brings together vaccine leaders and policy makers from around the globe. Attendees at this highly successful event were fortunate enough to hear this exciting presentation delivered by Sarah Gilbert from The Jenner Institute entitiled: ‘Vaccine development using two immunopotent viral vectors; adenoviruses (Ad) and modified Vaccinia virus Ankara (MVA)'

Download the full presentation here >

For more information about this and other topics discussed at the World Vaccine Congress Europe, subscribe to the Vaccine Nation newsletter, or visit the event website.

For more updates on the vaccines industry, follow us on Twitter: @vaccinenation or join our LinkedIn group: Vaccine Nation

Leave a Reply

Your email address will not be published. Required fields are marked *